QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.105858v1 319/1/488    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vyas, P. M. Articles by Svensson, C. K. Search for Related Content PubMed PubMed Citation Articles by Vyas, P. M. Articles by Svensson, C. K.

CELLULAR AND MOLECULAR

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450

Divisions of Pharmaceutics (P.M.V., S.R., F.D.K., C.K.S.) and Medicinal and Natural Products Chemistry (T.E.P.), College of Pharmacy, University of Iowa, Iowa City, Iowa; Department of Pharmaceutical Sciences, St. Jude Children's Hospital, Memphis, Tennessee (J.L., E.G.S.); Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (J.B., J.A.G.); and Department of Pediatrics and Pharmacology and Toxicology, Medical College of Wisconsin and Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, Wisconsin (K.L.M., R.N.H.)

Cutaneous drug reactions (CDRs) are among the most common adverse drug reactions and are responsible for numerous minor to life-threatening complications. Several arylamine drugs, such as sulfamethoxazole (SMX) and dapsone (DDS), undergo bioactivation, resulting in adduction to cellular proteins. These adducted proteins may initiate the immune response that ultimately results in a CDR. Recent studies have demonstrated that normal human epidermal keratinocytes (NHEKs) can bioactivate these drugs, resulting in protein haptenation. We sought to identify the enzyme(s) responsible for this bioactivation in NHEKs. Using immunofluorescence confocal microscopy and an adduct-specific enzyme-linked immunosorbent assay (ELISA), we found that N-acetylation of the primary amine of SMX and DDS markedly reduced the level of protein haptenation in NHEKs. Detection of mRNA and/or protein confirmed the presence of CYP3A4, CYP3A5, and CYP2E1 in NHEKs. In contrast, although a faint band suggestive of CYP2C9 protein was detected in one NHEK sample, a CYP2C9 message was not detectable. We also examined the ability of chemical inhibitors of cytochromes P450 (aminobenzotriazole and 1-dichloroethylene) and cyclooxygenase (indomethacin) to reduce protein haptenation when NHEKs were incubated with SMX or DDS by either confocal microscopy or ELISA. These inhibitors did not significantly attenuate protein adduction with either SMX or DDS, indicating that cytochromes P450 and cyclooxygenase do not play important roles in the bioactivation of these xenobiotics in NHEKs and thus suggesting the importance of other enzymes in these cells.

Address correspondence to: Dr. Craig K. Svensson, Dean, College of Pharmacy, Nursing, and Health Sciences, Purdue University, West Lafayette, IN 47907. E-mail: svensson{at}purdue.edu

This article has been cited by other articles:

				C. K. Svensson Biotransformation of Drugs in Human Skin Drug Metab. Dispos., February 1, 2009; 37(2): 247 - 253. [Abstract] [Full Text] [PDF]

				S. Roychowdhury, P. M. Vyas, and C. K. Svensson Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells Drug Metab. Dispos., April 1, 2007; 35(4): 676 - 681. [Abstract] [Full Text] [PDF]